Master The Pharmacy Technician Certification Exam PTCE

Question 1

A vial of antibiotic for IM injection contains 1 g in 3 mL. What is the concentration in mg/mL?

Your Answer: Option(s)

Correct Answer: Option(s) B

Rationale

The concentration of the antibiotic in the vial is 333.33 mg/mL.

To find the concentration in mg/mL, we convert the grams to milligrams (1 g = 1000 mg) and then divide by the volume in milliliters. Thus, 1000 mg divided by 3 mL equals approximately 333.33 mg/mL.

A) 300
This choice is incorrect because it suggests a concentration that results from dividing 900 mg by 3 mL, which does not reflect the actual amount of antibiotic present in the vial. The correct calculation shows that there are 1000 mg in total, leading to a higher concentration.

B) 333.33
This is the correct answer, as it accurately represents the concentration calculated by dividing 1000 mg by 3 mL. This calculation yields a concentration of approximately 333.33 mg/mL.

C) 600
This option is incorrect because it implies that the concentration is derived from dividing 1800 mg by 3 mL, which does not correspond to the amount of antibiotic present in the vial. The total amount available is only 1000 mg, leading to a lower concentration.

D) 666.66
This choice is incorrect as it would suggest a concentration resulting from dividing 2000 mg by 3 mL, which is again not reflective of the actual quantity of antibiotic in the vial. The true concentration is much lower due to the actual amount of 1000 mg present.

Conclusion
The correct concentration of the antibiotic in the vial is 333.33 mg/mL, derived from converting grams to milligrams and dividing by the volume. Understanding how to calculate concentration is crucial in pharmacology, ensuring accurate dosing and effective treatment outcomes. The other choices misrepresent the total available amount, leading to incorrect conclusions about the concentration.

Select an answer to continue →

Question 2

According to iPLEDGE, the maximum days' supply of isotretinoin permitted per fill is:

Your Answer: Option(s)

Correct Answer: Option(s) B

Rationale

According to iPLEDGE, the maximum days' supply of isotretinoin permitted per fill is 30.

The iPLEDGE program mandates that the maximum supply of isotretinoin for each prescription fill is limited to 30 days to help ensure patient safety and mitigate risks associated with the medication, which is used for severe acne treatment.

A) 7
A maximum supply of 7 days is insufficient and does not comply with the iPLEDGE regulations. This choice does not reflect the allowable duration for isotretinoin prescriptions, which could disrupt the continuity of treatment and patient compliance.

B) 30
This is the correct answer, as iPLEDGE clearly states that isotretinoin prescriptions can only be filled for a maximum of 30 days at a time. This limitation is designed to monitor and manage the serious side effects associated with the drug effectively.

C) 60
Permitting a 60-day supply would exceed the limits set by iPLEDGE and could pose a greater risk of misuse or complications from the medication. Such an extended supply is not aligned with the safety protocols established for isotretinoin.

D) 90
A 90-day supply is also not allowed under the iPLEDGE program, as it would increase the potential for patient harm and complicate the monitoring process for the side effects associated with isotretinoin. This choice fails to adhere to the program's guidelines.

Conclusion
The iPLEDGE program restricts isotretinoin prescriptions to a maximum of 30 days' supply per fill to ensure patient safety and effective monitoring of treatment. This regulation is crucial for managing the risks of the medication, while the other options either exceed this limit or do not align with the program's safety protocols. Understanding these guidelines is essential for healthcare providers prescribing isotretinoin.

Select an answer to continue →

Question 3

Which of the following medications must be transported and handled according to the guidelines found in USP Chapter 800?

Your Answer: Option(s)

Correct Answer: Option(s) D

Rationale

Anastrozole must be transported and handled according to the guidelines found in USP Chapter 800.

Anastrozole is classified as a hazardous drug, requiring specific handling and transportation procedures as outlined in USP Chapter 800. This chapter provides guidelines to ensure the safety of healthcare workers and patients when dealing with hazardous medications.

A) Acyclovir
Acyclovir is an antiviral medication used primarily for herpes simplex virus infections and is not classified as a hazardous drug. Therefore, it does not require the same stringent handling and transportation guidelines specified in USP Chapter 800.

B) Albuterol
Albuterol is a bronchodilator commonly used to treat asthma and other respiratory conditions. It is not considered a hazardous drug and does not fall under the regulations outlined in USP Chapter 800, which focuses on medications that pose risks to personnel handling them.

C) Amantadine
Amantadine is an antiviral medication used to treat and prevent influenza A and for Parkinson's disease. While it has specific safety considerations, it is not classified as a hazardous drug according to USP Chapter 800, thus exempting it from the chapter's handling requirements.

D) Anastrozole
Anastrozole is an aromatase inhibitor used in the treatment of breast cancer and is classified as a hazardous drug. This categorization necessitates adherence to the guidelines of USP Chapter 800, which includes proper storage, handling, and disposal practices to minimize exposure risks.

Conclusion
Among the medications listed, only anastrozole is considered hazardous and must be managed according to USP Chapter 800 guidelines. The classification as a hazardous drug is critical for ensuring safety in handling and transporting, while the other options—acyclovir, albuterol, and amantadine—are not classified as hazardous and therefore do not require such stringent measures. Understanding these classifications is vital for promoting safety in medication management practices.

Select an answer to continue →

Question 4

A root-cause analysis (RCA) should be completed in the event of a:

Your Answer: Option(s)

Correct Answer: Option(s) B

Rationale

A root-cause analysis (RCA) should be completed in the event of a near miss.

A near miss represents an incident where an error could have led to harm but did not, making it critical to investigate to prevent future occurrences. Conducting a root-cause analysis in such cases helps identify underlying issues and implement preventive measures.

A) Medication recall.
A medication recall involves withdrawing a drug from the market due to safety concerns or defects. While important, it is a response to confirmed problems rather than an analysis of errors or near misses. An RCA is typically not warranted for recalls since the issues have already been identified and addressed by regulatory authorities.

C) Predictable side effect.
Predictable side effects are known reactions that occur with certain medications, which are typically documented and communicated to patients. Since these effects are expected and not incidents of error, they do not require an RCA. Instead, they are managed through patient education and monitoring rather than investigation into root causes.

D) Drug utilization review.
A drug utilization review assesses the appropriateness of drug prescriptions and their usage patterns, aiming to ensure optimal therapeutic outcomes. While it is a valuable process for improving medication management, it does not involve investigating errors or incidents that have the potential to cause harm, which is the primary focus of an RCA.

Conclusion
Root-cause analysis (RCA) is essential for understanding and preventing errors, particularly in the case of near misses where harm was narrowly avoided. Unlike medication recalls, predictable side effects, or drug utilization reviews, a near miss signifies a missed opportunity for safety that necessitates thorough investigation. By identifying and addressing root causes, healthcare organizations can enhance patient safety and prevent future incidents.

Select an answer to continue →

Question 5

A patient who is hypersensitive to ciprofloxacin should have noted in their electronic profile that they are allergic to:

Your Answer: Option(s)

Correct Answer: Option(s) B

Rationale

A patient who is hypersensitive to ciprofloxacin should have noted in their electronic profile that they are allergic to fluoroquinolones.

Ciprofloxacin is a member of the fluoroquinolone class of antibiotics, so an allergy to ciprofloxacin indicates a sensitivity to this class of medications as a whole. Patients with such hypersensitivity are at risk of experiencing similar allergic reactions to other drugs within the fluoroquinolone category.

A) macrolides.
Macrolides, such as azithromycin and erythromycin, are a distinct class of antibiotics that function differently from fluoroquinolones. An allergy to ciprofloxacin does not imply an allergy to macrolides, as they have different chemical structures and mechanisms of action.

B) fluoroquinolones.
As mentioned, ciprofloxacin is a fluoroquinolone antibiotic. Therefore, if a patient is hypersensitive to ciprofloxacin, they should also avoid other fluoroquinolones, as cross-reactivity is common within drug classes. This choice directly correlates with the allergy indicated.

C) penicillins.
Penicillins are another separate class of antibiotics that include drugs such as amoxicillin and penicillin G. An allergy to ciprofloxacin does not indicate any hypersensitivity to penicillins, as these drugs do not share structural or pharmacological similarities with fluoroquinolones.

D) sulfonamides.
Sulfonamides, including drugs like sulfamethoxazole, are a different class of antibiotics that also do not relate to fluoroquinolones. An allergy to ciprofloxacin does not necessitate an allergy to sulfonamides, as they function independently in treating infections.

Conclusion
In summary, a patient allergic to ciprofloxacin should have a noted allergy to fluoroquinolones due to the shared properties and potential for cross-reactivity within this antibiotic class. Allergies to other classes such as macrolides, penicillins, and sulfonamides do not apply to this specific situation, highlighting the importance of accurate electronic medical records in managing patient allergies effectively.

Select an answer to continue →

Free Preview Ended

You've seen the first 5 questions.
Subscribe to unlock the remaining 85 questions + full features.

Unlock Full Exam See Other Exams

The concentration of the antibiotic in the vial is 333.33 mg/mL.

According to iPLEDGE, the maximum days' supply of isotretinoin permitted per fill is 30.

Anastrozole must be transported and handled according to the guidelines found in USP Chapter 800.

A root-cause analysis (RCA) should be completed in the event of a near miss.

A patient who is hypersensitive to ciprofloxacin should have noted in their electronic profile that they are allergic to fluoroquinolones.

Free Preview Ended

Unlock Full Access

You are leaving this quiz

You're in the middle of a quiz

Report an Issue

Rate this Practice Test